Tracheal necrosis after sandwich immunotherapy and stereotactic body radiotherapy for lung cancer
Article Sidebar
Main Article Content
Abstract
-
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Lo SS, Fakiris AJ, Chang EL, et al. Stereotactic body radiation therapy: A novel treatment modality. Nat Rev Clin Oncol 2010;7(1):44-54. https://doi.org/10.1038/ nrclinonc.2009.188
Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006;24(30):4833-4839. https://doi. org/10.1200/JCO.2006.07.5937
Lindberg K, Onjukka E. Medical consequences of radiation exposure of the bronchi – what can we learn from high-dose precision radiation therapy? J Radiol Prot 2021;41(4). https://doi.org/10.1088/1361-6498/ac28ef
Song SY, Choi W, Shin SS, et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 2009;66(1):88-93. https://doi.org/10.1016/j.lungcan.2008.12.016
Jesus HNR, Rocha DJPG, Ramos RTJ, et al. Pan-genomic analysis of Corynebacterium amycolatum gives insights into molecular mechanisms underpinning the transition to apathogenic phenotype. Front Microbiol 2022;13:1011578. https://doi.org/10.3389/ fmicb.2022.1011578
Aerni MR, Parambil JG, Allen MS, Utz JP. Nontraumatic disruption of the fibrocartilaginous trachea: Causes and clinical outcomes. Chest 2006;130(4):1143- 1149. https://doi.org/10.1378/chest.130.4.1143
Louie BH, Stramiello J, Senyei G, et al. Necrotizing tracheitis complicated by tracheal wall perforation. Ear Nose Throat J 2022;101(10_Suppl):26S-29S. https://doi. org/10.1177/01455613221123664
WarriorK,PandyaS,TranB.Trachealnecrosis:Apathologicmediastinalwindow.Am J Respir Crit Care Med 2017;195:A6043. https://www.atsjournals.org/doi/abs/10.1164/ ajrccm-conference.2017.195.1_MeetingAbstracts.A6043 (accessed 8 May 2024).
Corradetti MN, Haas AR, Rengan R. Central-airway necrosis after stereotactic body- radiation therapy. N Engl J Med 2012;366(24):2327-2329. https://doi.org/10.1056/ nejmc1203770
HaseltineJM,RimnerA,GelblumDY,etal.Fatalcomplicationsafterstereotacticbody radiation therapy for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol 2016;6(2):e27-e33. https://doi.org/10.1016/j.prro.2015.09.012
Louvel G, Bahleda R, Ammari S, et al. Immunotherapy and pulmonary toxicities: Can concomitant immune-checkpoint inhibitors with radiotherapy increase the risk of radiation pneumonitis? Eur Respir J 2018;51(1):1701737. https://doi. org/10.1183/13993003.01737-2017
Tian S, Switchenko JM, Buchwald ZS, et al. Lung stereotactic body radiation therapy and concurrent immunotherapy: A multicenter safety and toxicity analysis. Int J Radiat Oncol Biol Phys 2020;108(1):304-313. https://doi.org/10.1016/j.ijrobp.2019.12.030
Ariza-Prota M, Morales A, Grajeda J, et al. Successful healing of tracheal radionecrosis: Role of hyperbaric oxygen therapy. Chest 2016;150(6):e147-e150. https://doi. org/10.1016/j.chest.2016.03.027